Modafinil Monotherapy in Poststroke Depression
نویسندگان
چکیده
منابع مشابه
Neurobiology of poststroke depression.
welcomes Letters to the Editor and will publish them, if suitable, as space permits. They should not exceed 750 words (excluding references) and may be subject to editing or abridgment. Please submit letters in duplicate, typed double-spaced. Include a fax number for the corresponding author and a completed copyright transfer agreement form (published in every issue). To the Editor: Eriksson et...
متن کاملFluoxetine in Early Poststroke Depression
Background and Purpose—Early poststroke depression (PSD) is a frequent and specific entity that impairs the rehabilitation and functional recovery of hemiplegic patients. This trial was designed to study the efficacy and tolerance of fluoxetine (FLX) in the treatment of early PSD. Methods—This was a multicenter, double-blind, placebo-controlled study. Recent hemiplegic patients (,3 months) suff...
متن کاملIs poststroke depression a vascular depression?
As we learn more about the relationships between depression and cerebrovascular disease (CVD), a complex picture is emerging in which the chain of causality seems to spiral on itself: progressive or focal brain damage, cognitive impairment, depressive symptoms, dementia, and cardiovascular diseases, all seem to be liable to lead to one or another. Stroke may lead to depression, and the inverse ...
متن کاملCare management for poststroke depression.
See related article, pages 998–1003. Depression is a common consequence of stroke, occurring in one third of people at some point after stroke.1 It is important that depression is viewed as more than an understandable consequence of a sudden-onset major life event, because depression after stroke is associated with poorer rehabilitation outcome,2,3 lower quality of life,4 and suicide.5 Yet few ...
متن کاملModafinil as an adjunctive treatment to sleep deprivation in depression.
Sleep deprivation (SD) is a rapid-acting treatment for depression, but its clinical efficacy is hampered by high relapse rates after recovery sleep, and its effectiveness is reduced by the demanding effort needed for the patient to stay awake. To our knowledge, this is the first reported case of a successful treatment of depression with the combination of SD and the wakefulness-promoting agent ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Psychosomatics
سال: 2004
ISSN: 0033-3182
DOI: 10.1176/appi.psy.45.1.80